Long-term clinical and biochemical follow-up in medullary thyroid carcinoma: A single institution's experience over 20 years

Annals of Surgery

Volumn 246, Issue 5, 2007, Pages 815-821

  Cupisti, Kenko ^a   Wolf, Achim ^a   Raffel, Andreas ^a   Schott, Matthias ^a   Miersch, Daniel ^a   Yang, Qin ^a   Eisenberger, Claus F ^a   Röher, Hans D ^a   Knoefel, Wolfram T ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOCHEMISTRY; CANCER CLASSIFICATION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CELL HYPERPLASIA; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEN2 GENE; OUTCOMES RESEARCH; PRIORITY JOURNAL; SCHOOL CHILD; THYROID MEDULLARY CARCINOMA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CALCITONIN; CARCINOMA, MEDULLARY; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; RETROSPECTIVE STUDIES; SURVIVAL RATE; THYROID NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 35648968625     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31813e66b9     Document Type: Article

References (31)

1. Favia G, Iacobone M. Medullary thyroid carcinoma: state of the art. G Chir. 2005;26:405-409.
2. Gülben K, Berberoglu U, Boyabatl M. Prognostic factors for sporadic medullary thyroid carcinoma. World J Surg. 2006;30:84-90.
3. Thyroid Carcinoma Task Force. AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. American Association of Clinical Endocrinologists. American College of Endocrinology Endocrine. Practice. 2001;7:202-220.
4. Dotzenrath C, Goretzki PE, Cupisti K, et al. Is there any consensus in diagnostic and operative strategy with respect to medullary thyroid cancer? A questionnaire answered by 73 endocrine surgical units. Langenbecks Arch Surg. 2001;386:47-52.
5. Bergholm U, Adami HO, Auer G, et al. Histopathologic characteristics and nuclear DNA content as prognostic factors in medullary thyroid carcinoma: a nationwide study in Sweden. The Swedish MTC Study Group. Cancer. 1989;64:135-142.
6. Bergholm U, Bergström R, Ekbom A. Long term follow-up of patients with medullary carcinoma of the thyroid Cancer. 1997;79:132-138.
7. Hyer SL, Vini L, A'Hern R, et al. Medullary thyroid cancer: multivariate analysis of prognostic factors influencing survival. Eur J Surg Oncol. 2000;26:686-690.
8. Kebebew E, Ituarte PHG, Siperstein AE, et al. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer. 2000;88:1139-1148.
9. Saad MF, Ordonez NG, Rashid RK, et al. Medullary carcinoma of the thyroid: a study of the clinical features and prognostic factors in 161 patients. Medicine. 1984;63:319-342.
10. Scopsi L, Sampietro G, Boracchi P, et al. Multivariate analysis of prognostic factors in sporadic medullary carcinoma of the thyroid. Cancer. 1996;78:2173-2183.
11. Ukkat J, Gimm O, Brauckhoff M, et al. Single center experience in primary surgery for medullary thyroid carcinoma. World J Surg. 2004;28:1271-1274.
12. Sobin LH, Wittekind C, eds. TNM Classification of Malignant Tumours. New York: Wiley; 1997:47-50.
13. Cupisti K, Simon D, Wolf A, et al. Surgical treatment of postoperative, incidentally diagnosed small sporadic C-cell-carcinomas of the thyroid. Langenbecks Arch Surg. 2000;385:526-530.
14. Raffel A, Cupisti K, Krausch M, et al. Incidentally found medullary thyroid cancer: treatment rationale for small tumors. World J Surg. 2004;28:397-401.
15. Robbins KT, Medina JE, Wolfe GT, et al. Standardizing neck dissection terminology. Official report of the Academy's Committee for Head and Neck Surgery and Oncology. Arch Otolaryngol Head Neck Surg. 1991;117:601-605.
16. Clayman GL, Frank DK. Selective neck dissection of anatomically appropriate levels is as efficacious as modified radical neck dissection for elective treatment of the clinically negative neck in patients with squamous cell carcinoma of the upper respiratory and digestive tracts. Arch Otolaryngol Head Neck Surg. 1998;124:348-352.
17. Sand M, Gelos M, Sand D, et al. Serum calcitonin negative medullary thyroid carcinoma. World J Surg Oncol. 2006;4:97.
18. Fleming JB, Lee JE, Bouvet M, et al. Surgical strategy for the treatment of medullary thyroid carcinoma. Ann Surg. 1999;230:697-707.
19. Moley JF, Debenedetti MK, Dilley WG, et al. Surgical management of patients with persistent or recurrent medullary thyroid cancer. J Int Med. 1998;243:521-526.
20. Yen TWF, Shapiro SE, Gagel RF, et al. Medullary thyroid carcinoma: results of a standardized surgical approach in a contemporary series of 80 consecutive patients. Surgery. 2003;134:890-901.
21. Quayle FJ, Moley JF. Medullary thyroid carcinoma: management of lymph node metastases. Curr Treat Options Oncol. 2005;6:347-354.
22. Chen H, Roberts JR, Ball DW, et al. Effective long-term palliation of symptomatic, incurable metastatic medullary thyroid cancer by operative resection. Ann Surg. 1998;227:887-895.
23. Cohen EG, Shaha AR, Rinaldo A, et al. Medullary thyroid carcinoma. Acta Otolaryngol. 2004;124:544-557.
24. Quayle FJ, Moley JF. Medullary thyroid carcinoma: including MEN 2A and MEN 2B Syndromes. J Surg Oncol. 2005;89:122-129.
25. de Groot JW, Plaza Menacho I, Schepers H, et al. Cellular effects of imatinib on medullary thyroid cancer cells harboring multiple endocrine neoplasia Type 2A and 2B associated RET mutations. Surgery. 2006;139:806-814.
26. Cengic N, Baker CH, Schutz M, et al. A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression. J Clin Endocrinol Metab. 2005;90:4457-4464.
27. Schott M. Immunesurveillance by dendritic cells: potential implication for immunotherapy of endocrine cancers. Endocr Relat Cancer. 2006;13:779-795.
28. Fromigue J, De Baere T, Baudin E, et al. Chemoembolization for liver metastases from medullary thyroid carcinoma. J Clin Endocrinol Metab. 2006;91:2496-2499.
29. Brierley J, Tsang R, Simpson WJ, et al. Medullary thyroid cancer: analysis of survival and prognostic factors and the role of radiation therapy in local control. Thyroid. 1996;6:305-310.
30. Dottorini ME, Assi A, Sironi M, et al. Multivariate analysis of patients with medullary thyroid carcinoma: prognostic significance and impact on treatment of clinical and pathologic variables. Cancer. 1996;77:1556-1565.
31. Clark JR, Fridman TR, Odell MJ, et al. Prognostic variables and calcitonin in medullary thyroid cancer. Laryngoscope. 2005;115:1145-1150.